Novartis Ag (NVS) Inventory (2009 - 2025)

Novartis Ag (NVS) has 14 years of Inventory data on file, last reported at $6.3 billion in Q4 2025.

• Quarterly Inventory rose 9.54% year-over-year to $6.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 billion (up 9.54% YoY) and the FY2025 annual result came in at $6.3 billion, up 9.54% from the prior year.
• Inventory fell to $6.3 billion in Q4 2025 per NVS's latest filing, from $6.3 billion in the prior quarter.
• The five-year high for Inventory was $8.2 billion in Q2 2023, with the low at $5.7 billion in Q4 2024.
• Average Inventory over 5 years is $6.6 billion, with a median of $6.5 billion recorded in 2021.
• Year-over-year, Inventory surged 8365.48% in 2021 and plunged 30.15% in 2024.
• Novartis Ag's Inventory stood at $6.7 billion in 2021, then rose by 7.64% to $7.2 billion in 2022, then fell by 17.59% to $5.9 billion in 2023, then retreated by 3.21% to $5.7 billion in 2024, then increased by 9.54% to $6.3 billion in 2025.
• Business Quant data shows NVS's Inventory at $6.3 billion in Q4 2025, $6.3 billion in Q2 2025, and $5.7 billion in Q4 2024.